|
NOP14 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.020400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.182100E-02 |
| Normal-vs-Stage2 |
2.288100E-02 |
| Normal-vs-Stage3 |
3.967800E-01 |
| Normal-vs-Stage4 |
1.747360E-01 |
| Stage1-vs-Stage2 |
2.944000E-01 |
| Stage1-vs-Stage3 |
1.487820E-01 |
| Stage1-vs-Stage4 |
7.530600E-01 |
| Stage2-vs-Stage3 |
7.748200E-02 |
| Stage2-vs-Stage4 |
2.712200E-01 |
| Stage3-vs-Stage4 |
4.815400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.054200E-02 |
| Normal-vs-AfricanAmerican |
5.303400E-03 |
| Normal-vs-Asian |
6.096500E-02 |
| Caucasian-vs-AfricanAmerican |
1.686430E-01 |
| Caucasian-vs-Asian |
4.944200E-01 |
| AfricanAmerican-vs-Asian |
4.613000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.243000E-01 |
| Normal-vs-Female |
1.133570E-02 |
| Male-vs-Female |
2.387600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.263800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.541800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.554810E-01 |
| Normal-vs-Age(81-100Yrs) |
8.657200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.044400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.232600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.967000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.495400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.721200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.063600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.090000E-02 |
| Classical-VS-Follicular |
2.111900E-02 |
| Classical-VS-Other |
1.336990E-01 |
| Classical-VS-Normal |
1.156450E-03 |
| Tall-VS-Follicular |
4.463200E-01 |
| Tall-VS-Other |
7.369600E-01 |
| Tall-VS-Normal |
7.361600E-01 |
| Follicular-VS-Other |
5.302600E-01 |
| Follicular-VS-Normal |
5.695200E-01 |
| Other-VS-Normal |
6.707800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.122300E-02 |
| Normal-vs-N1 |
8.413400E-01 |
| N0-vs-N1 |
7.476000E-02 |
|
|
